The National Institute of Diabetes and Digestive and Kidney Diseases will fund the university’s work to examine tissue-specific metabolic reprogramming in diabetes complications.
The university’s team of researchers specifically proposes that diabetes disrupts basic metabolic pathways in complication-prone tissues and that understanding these altered pathways will provide new targets for drug therapies that could prevent or treat diabetes complications, including diabetes-related blindness, nerve damage and kidney failure.
Related Articles on University of Michigan Health System:
University of Michigan Health Partners With Great Lakes Health Information Exchange
University of Michigan Health Pushes Back Opening of Women’s, Children’s Hospitals
U Michigan Nurses, Leadership Battle Over Contract Negotiations
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
